PureTech Founded Entity Gelesis Appoints Procter & Gamble Veteran Jane Wildman to Board of DirectorsBusiness Wire • 04/26/21
Vedanta Biosciences to Present at the 2021 Jefferies Virtual Microbiome-Based Therapeutics SummitBusiness Wire • 04/15/21
PureTech Presents Promising Preclinical Data from LYT-210 Immuno-Oncology Program at American Association for Cancer Research (AACR) Annual MeetingBusiness Wire • 04/12/21
PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Potential Treatment for Patients with COVID Brain FogBusiness Wire • 04/07/21
PureTech Founded Entity Akili Announces the Results of EndeavorRx™ Clinical Study in Pediatric ADHD Published in Nature Digital MedicineBusiness Wire • 03/26/21
PureTech Announces Publication of Glyph™ Platform Preclinical Proof-of-Concept Study in Journal of Controlled ReleaseBusiness Wire • 02/25/21
PureTech Founded Entity Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in SchizophreniaBusiness Wire • 02/25/21
PureTech Founded Entity Vor Biopharma Closes Over $200M Initial Public OfferingBusiness Wire • 02/10/21
PureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.Business Wire • 01/12/21
PureTech Initiates Phase 2 trial of LYT-100 (Deupirfenidone) in Long COVID Respiratory Complications and Related SequelaeBusiness Wire • 12/03/20
Vedanta Biosciences Appoints Troy Ignelzi, Chief Financial Officer at Karuna Therapeutics, to Its Board of DirectorsBusiness Wire • 11/24/20
PureTech Founded Entity Vedanta Biosciences Appoints Troy Ignelzi, Chief Financial Officer at Karuna Therapeutics, to its Board of DirectorsBusiness Wire • 11/24/20